APAC, Gastrointestinal Drugs Market Segmented, by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others), by Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others), by Route of Administration (Oral, and Parenteral), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138331
- Pages: 200
-
Format:
Report Overview
The APAC Gastrointestinal Drugs Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5% during the forecast period
Gastrointestinal (GI) disorders are the medical conditions related to the digestive system that affect the colon, small and large intestine, and rectum. The disorders include constipation, irritable bowel, ulcerative colitis, and peptic ulcer diseases. These disorders are characterized by various symptoms such as pain, bloating, diarrhoea, nausea, and vomiting. These disorders constitute a large proportion of outpatients and frequent hospital visits. A wide range of GI drugs is commercially available in the market for the treatment of various conditions. Additionally, rising investments in the development of biologics and the emergence of a biosimilar are expected to drive the growth of the market in the forecast period
Market Drivers and Restraints
Rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics are the key factors driving the growth of gastrointestinal drugs. However, side effects associated with the drugs is the major factor hindering the market growth in Asia Pacific
1. APAC Gastrointestinal Drugs Market Overview
A. Market Size
2. APAC Gastrointestinal Drugs Market Growth Drivers and Restraints
A. Rising prevalence of gastrointestinal (GI) diseases, and increase in development of biologics
B. Side effects associated with the drugs
3. APAC Gastrointestinal Drugs Market Segmentation
A. By Drug Class
I. Acid Neutralizers
II. Antidiarrheal and Laxatives
III. Anti-Inflammatory Drugs
IV. Antiemetic
V. Antinauseants
B. By Route of Administration
I. Oral
II. Parental
C. By Application
I. Inflammatory Ulcerative Colitis
II. Crohn's Disease
III. Irritable Bowel Syndrome
IV. Gastroenteritis
V. Celiac Disease
VI. Others
D. By Distribution Channel
I. Hospital Pharmacies
II. Online Pharmacies
III. Retail Pharmacies
4. APAC Infectious Diseases Diagnostics Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Johnson and Johnson Services, Inc, Company overview, Product & Services, Strategies & Financials
B. GlaxoSmithKline plc, Company overview, Product & Services, Strategies & Financials
C. AstraZeneca, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
